Bordoloi D - Search Results

1

Tocotrienols: The promising analogues of vitamin E for cancer therapeutics.

Sailo BL, Banik K, Padmavathi G, Javadi M, Bordoloi D, Kunnumakkara AB. Sailo BL, et al. Among authors: bordoloi d. Pharmacol Res. 2018 Apr;130:259-272. doi: 10.1016/j.phrs.2018.02.017. Epub 2018 Feb 27. Pharmacol Res. 2018. PMID: 29496592 Review.

2

Possible use of Punica granatum (Pomegranate) in cancer therapy.

Khwairakpam AD, Bordoloi D, Thakur KK, Monisha J, Arfuso F, Sethi G, Mishra S, Kumar AP, Kunnumakkara AB. Khwairakpam AD, et al. Among authors: bordoloi d. Pharmacol Res. 2018 Jul;133:53-64. doi: 10.1016/j.phrs.2018.04.021. Epub 2018 May 2. Pharmacol Res. 2018. PMID: 29729421 Review.

3

Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.

Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Banik K, et al. Among authors: bordoloi d. Pharmacol Res. 2019 Jun;144:192-209. doi: 10.1016/j.phrs.2019.04.004. Epub 2019 Apr 17. Pharmacol Res. 2019. PMID: 31002949 Review.

4

Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far.

Bordoloi D, Roy NK, Monisha J, Padmavathi G, Kunnumakkara AB. Bordoloi D, et al. Recent Pat Anticancer Drug Discov. 2016;11(1):67-97. doi: 10.2174/1574892810666151020101706. Recent Pat Anticancer Drug Discov. 2016. PMID: 26537958 Review.

5

Potential of butein, a tetrahydroxychalcone to obliterate cancer.

Padmavathi G, Rathnakaram SR, Monisha J, Bordoloi D, Roy NK, Kunnumakkara AB. Padmavathi G, et al. Among authors: bordoloi d. Phytomedicine. 2015 Dec 1;22(13):1163-71. doi: 10.1016/j.phymed.2015.08.015. Epub 2015 Oct 13. Phytomedicine. 2015. PMID: 26598915 Review.

6

Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer.

Monisha J, Roy NK, Bordoloi D, Kumar A, Golla R, Kotoky J, Padmavathi G, Kunnumakkara AB. Monisha J, et al. Among authors: bordoloi d. Curr Drug Targets. 2017;18(2):232-253. doi: 10.2174/1389450117666160201112330. Curr Drug Targets. 2017. PMID: 26844566 Review.

7

Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer.

Roy NK, Bordoloi D, Monisha J, Padmavathi G, Kotoky J, Golla R, Kunnumakkara AB. Roy NK, et al. Among authors: bordoloi d. Curr Drug Targets. 2017;18(4):421-435. doi: 10.2174/1389450117666160307145236. Curr Drug Targets. 2017. PMID: 26953242 Review.

8

The potential role of boswellic acids in cancer prevention and treatment.

Roy NK, Deka A, Bordoloi D, Mishra S, Kumar AP, Sethi G, Kunnumakkara AB. Roy NK, et al. Among authors: bordoloi d. Cancer Lett. 2016 Jul 10;377(1):74-86. doi: 10.1016/j.canlet.2016.04.017. Epub 2016 Apr 14. Cancer Lett. 2016. PMID: 27091399 Review.

9

NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization.

Monisha J, Padmavathi G, Roy NK, Deka A, Bordoloi D, Anip A, Kunnumakkara AB. Monisha J, et al. Among authors: bordoloi d. Curr Pharm Des. 2016;22(27):4173-200. doi: 10.2174/1381612822666160609110231. Curr Pharm Des. 2016. PMID: 27291284 Review.

10

Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. Kunnumakkara AB, et al. Among authors: bordoloi d. Br J Pharmacol. 2017 Jun;174(11):1325-1348. doi: 10.1111/bph.13621. Epub 2016 Oct 21. Br J Pharmacol. 2017. PMID: 27638428 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters